 contribut antibodi respons gene-encod product rev tat proteas develop aid individu relat antibody-respons profil coli-produc nef rev tat proteas protein risk aid store serum sampl cohort symptom-fre men seroposit antibodi structur protein men antibodi aid attack rate month follow-up men neg versu posit antibodi profil tat proteas differ attack rate No signific differ men neg versu posit antibodi profil differ aid attack rate cohort men serum antigen posit versu neg men low versu normal lymphocyt count respect antibody-respons profil differ core antibody-neg antibody-posit men subgroup men marker predict progress aid cohort persist antigenemia low anti-cor antibodi reactiv low cell count antibodi profil tat proteas predict outcom infect combin persist antigenemia low cell count neg antibodi profil nef proteas sensit specif progress aid low anti-cor antibodi reactiv